HRA Pharma creates
innovative products
to fill therapeutic gaps
in reproductive health
and endocrinology.
- February 2, 2012
Paris, France
NEJM features two positive pivotal trials of HRA Pharma compound ulipristal acetate for the treatment of uterine fibroids - December 16, 2011
Paris, France
HRA Pharma's partner, Preglem, the wholly owned subsidiary of Gedeon Richter Plc., receives positive CHMP opinion for uterine fibroids treatment.